Webinar | October 23, 2018

Rapid Methodologies For Biosafety Testing Of Biologic Therapeutics

Source: MilliporeSigma

Speed to market for biologic therapeutics is ever more critical. However, the critical safety tests for these molecules, for example screening for adventitious agents such as viral contaminants, can be time consuming as well as challenging and laborious. Join us for this webinar as we explore how rapid methodologies are being used to not only accelerate this process, but also enhance quality by reducing testing complexity. Existing technologies as well as emerging trends will be discussed, along with the implications these may have on the regulatory landscape.

In this webinar, you will learn:

  • Which existing and emerging technologies are having now, and will have in the future, an impact on biosaftey testing
  • The benefits as well as risks of employing rapid methods for biosafety screening
  • How the regulatory agencies are reacting to rapid testing methods as alternatives to existing methods